Crossmark

Renal tubule-targeted biomimetic nanodrugs achieve precise AKI treatment by halting pro-inflammatory crosstalk between proximal tubular epithelial cells and macrophages

Crossref DOI link: https://doi.org/10.1186/s12951-026-04983-1

Published Online: 2026-08-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Pengfei

Zhao, Lingshan

Yang, Liling

Huang, Lili

Zhang, Chenli

Tan, Ling

Su, Yuanyuan

Zhang, zheng

Deng, Jun https://orcid.org/0000-0002-9951-2393
Liao, Xiaohui
Funding

Funding for this research was provided by:

the National Natural Science Foundation of China (82570849)
License Information

Text and Data Mining valid from 2026-08-27

Accepted Manuscript valid from 2026-08-27
More Information

Article History

Received: 27 May 2026

Accepted: 21 August 2026

First Online: 27 August 2026

Declarations

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below